Gene · 6375
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas. | Front Immunol | 2022 | 35309316 | PubTator, text mining | PubMed |
| Mixed-Dimensional Formamidinium Bismuth Iodides Featuring In-Situ Formed Type-I Band Structure for Convolution Neural Networks. | Adv Sci (Weinh) | 2022 | 35307991 | PubTator, text mining | PubMed |
| Trajectory of immune evasion and cancer progression in hepatocellular carcinoma. | Nat Commun | 2022 | 35301339 | PubTator, text mining | PubMed |
| Analyzing Prognostic Hub Genes in the Microenvironment of Cutaneous Melanoma by Computer Integrated Bioinformatics. | Comput Intell Neurosci | 2022 | 35300397 | PubTator, text mining | PubMed |
| Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection. | Front Immunol | 2022 | 35296089 | PubTator, text mining | PubMed |
| Mechanism underlying the effect of Liujunzi decoction on advanced-stage non-small cell lung cancer in patients after first-line chemotherapy. | J Tradit Chin Med | 2022 | 35294130 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney. | JCI Insight | 2022 | 35290245 | PubTator, text mining | PubMed |
| Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study. | J Immunother Cancer | 2022 | 35288468 | PubTator, text mining | PubMed |
| Modulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation. | J Exp Med | 2022 | 35285873 | PubTator, text mining | PubMed |
| CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers. | Front Neurol | 2022 | 35280273 | PubTator, text mining | PubMed |
| Innate lymphoid cells in colorectal cancer. | Scand J Immunol | 2022 | 35274359 | PubTator, text mining | PubMed |
| The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist. | PLoS Pathog | 2022 | 35271688 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Porcine Naïve, Intermediate and Terminally Differentiated CD8+ T Cells. | Front Immunol | 2022 | 35265090 | PubTator, text mining | PubMed |
| Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease. | PLoS One | 2022 | 35263363 | PubTator, text mining | PubMed |
| Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells. | EMBO Mol Med | 2022 | 35263037 | PubTator, text mining | PubMed |
| Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19. | Per Med | 2022 | 35261286 | PubTator, text mining | PubMed |
| Co-occurrence of CDKN2A/B and IFN-I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma. | Mol Oncol | 2022 | 35253368 | PubTator, text mining | PubMed |
| Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients. | Mol Ther Methods Clin Dev | 2022 | 35252469 | PubTator, text mining | PubMed |
| Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy. | Clin Cancer Res | 2022 | 35247927 | PubTator, text mining | PubMed |
| Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma. | Hepatology | 2022 | 35243668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6375/papers?page=44